These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. T cell receptor beta-chain third complementarity-determining region gene usage is highly restricted among Sm-B autoantigen-specific human T cell clones derived from patients with connective tissue disease. Talken BL; Holyst MM; Lee DR; Hoffman RW Arthritis Rheum; 1999 Apr; 42(4):703-9. PubMed ID: 10211884 [TBL] [Abstract][Full Text] [Related]
7. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745 [TBL] [Abstract][Full Text] [Related]
10. [What's the significance of the HLA system in dermatology?]. Koeppel MC; Sayag J Ann Dermatol Venereol; 1988; 115(1):99-112. PubMed ID: 2967044 [No Abstract] [Full Text] [Related]
11. [Progress in study of autoantibodies in connective tissue diseases]. Mimori T Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):23-7. PubMed ID: 11963176 [No Abstract] [Full Text] [Related]
12. Immunological features of diffuse connective tissue diseases. Burgio GR; Martini A Eur J Pediatr; 1990 Jan; 149(4):224-31. PubMed ID: 2406145 [TBL] [Abstract][Full Text] [Related]
14. Immunological investigation in children with juvenile chronic arthritis. Sedivá A; Hoza J; Nĕmcová D; Pospísilová D; Bartůnková J; Vencovský J Med Sci Monit; 2001; 7(1):99-104. PubMed ID: 11208502 [TBL] [Abstract][Full Text] [Related]
15. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies. Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890 [TBL] [Abstract][Full Text] [Related]
16. Immunological analysis of pulmonary hypertension in connective tissue diseases. Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891 [TBL] [Abstract][Full Text] [Related]
17. [Antineutrophil cytoplasmic autoantibodies (ANCA)--in patients with connective tissue diseases]. Prus V; Sram K; Fustar V Reumatizam; 1994; 41(2):9-11. PubMed ID: 8693198 [TBL] [Abstract][Full Text] [Related]
18. [Immunology of systemic connective tissue diseases]. Hána I; Dostál C; Bardfeld R Cas Lek Cesk; 1984 Sep; 123(38-39):1178-81. PubMed ID: 6498919 [No Abstract] [Full Text] [Related]
19. [Endothelial antigenicity in diffuse connective tissue diseases]. de Mendonça LL; Yoshinari NH; Balthazar PA; Cossermelli W Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):293-7. PubMed ID: 8029603 [TBL] [Abstract][Full Text] [Related]